DOI QR코드

DOI QR Code

Lack of Prognostic Value of Blood Parameters in Patients Receiving Adjuvant Radiotherapy for Breast Cancer

  • Cihan, Yasemin Benderli (Department of Radiation Oncology, Kayseri Education and Research Hospital) ;
  • Arslan, Alaettin (Department of Radiation Oncology, Kayseri Education and Research Hospital) ;
  • Cetindag, Mehmet Faik (Department of Radiation Oncology, Ankara Education and Research Hospital) ;
  • Mutlu, Hasan (Department of Medical Oncology, Acıbadem Hospital)
  • Published : 2014.05.30

Abstract

Aim: To determine prognostic value of blood parameters on overall and progression-free survival in cases received adjuvant radiotherapy and chemotherapy with diagnosis of stage I-III breast cancer. Materials and Methods: We retrospectively reviewed files of 350 patients with non-metastatic breast cancer who were treated in the Radiation Oncology Department of Kayseri Teaching Hospital between 2005 and 2010. Pretreatment white blood cell (WBC), neutrophil, monocyte, basophil and eosinophil counts, and the neutrophil/lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) were recorded. The relationship between clinicopathological findings and blood parameters was assessed. Results: Overall, 344 women and 6 men were recruited. Median age was $55.3{\pm}0.3$ years (range: 22-86). Of the cases, 243 (61.4%) received radiotherapy while 329 (94.3%), received chemotherapy and 215 (61.4%) received hormone therapy. Mean overall survival (OS) and progression-free survival (PFS) was 84.4 and 78.8 months, respectively. During follow-up, 48 patients died due to either disease-related or non-related causes. Local recurrence was detected in 14 cases, while distant metastasis was noted in 45 cases. In univariate analysis, age, pathology, perinodal invasion were significantly associated with overall survival, whereas gender, stage and hormone therapy were significantly associated with progression-free survival. In multivariate analysis, histopathological diagnosis (OR: 0.3; 95%: 0.1-0.7; p=0.006) and perinodal invasion (OR: 0.1; 95% CI: 0.1-1.3; p=0.026) were significantly associated with overall survival, whereas tumor stage (OR: 2.1; 95% CI: 0.0-0.7; p=0.014) and hormone therapy (OR: 2.1; 95%: 1.2-3.8; p=0.010) were significantly associated with progression-free survival. Conclusions: It was found that serum inflammatory markers including WBC, neutrophil, lymphocyte and monocyte counts, and NLR and PLR had no effect on prognosis in patients with breast cancer who underwent surgery and received adjuvant radiotherapy and chemotherapy.

Keywords

References

  1. Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E (2013). Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev, 14, 6905-11. https://doi.org/10.7314/APJCP.2013.14.11.6905
  2. Aggarwal B, Gehlot P (2009). Inflammation and cancer: how friendly is the relationship for cancer patients? Current Opinion in Pharmacology, 9, 351-69. https://doi.org/10.1016/j.coph.2009.06.020
  3. Azab B, Bhatt VR, Phookan J, et al (2012). Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 19, 217-24. https://doi.org/10.1245/s10434-011-1814-0
  4. Azab B, Shah N, Radbel J, et al (2013). Pretreatment neutrophil/lymphocyte ratio is superior to platelet/ lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol, 30, 432. https://doi.org/10.1007/s12032-012-0432-4
  5. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al (2003). Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer, 88, 1721-6. https://doi.org/10.1038/sj.bjc.6600956
  6. Ceber E, Mermer G, Okcin F, et al (2013). Breast cancer risk and early diagnosis applications in Turkish women aged 50 and over. Asian Pac J Cancer Prev, 14, 5877-82. https://doi.org/10.7314/APJCP.2013.14.10.5877
  7. Engin H, Bilir C, Tekin IO (2013). Prognostic significance of peripheral blood flow cytometry parameters in patients with non-metastatic breast cancer. Asian Pac J Cancer Prev, 14, 7645-9. https://doi.org/10.7314/APJCP.2013.14.12.7645
  8. Gorelik E, Landsittel DP, Marrangoni AM, et al (2005). Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Bio-markers Prev, 14, 981-7. https://doi.org/10.1158/1055-9965.EPI-04-0404
  9. Harada A, Sekido N, Akahoshi T, et al (1994). Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol, 56, 559-64.
  10. Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer Prev, 14, 6221-5. https://doi.org/10.7314/APJCP.2013.14.11.6221
  11. Kassim SK, El-Salahy EM, Fayed ST, et al (2004). Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem, 37, 363-9. https://doi.org/10.1016/j.clinbiochem.2004.01.014
  12. Lyon DE, McCain NL, Walter J, Schubert C (2008). Cytokine comparisons between women with breast cancer and women with a negative breast biopsy. Nurs Res, 57, 51-8. https://doi.org/10.1097/01.NNR.0000280655.58266.6c
  13. Pierce BL, Ballard-Barbash R, Berstein L, et al (2009). Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 21, 3437-44.
  14. Proctor M, Morrison D, Talwar D, et al (2011). A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer, 47, 2633-41. https://doi.org/10.1016/j.ejca.2011.03.028
  15. Pusztai L, Mendoza TR, Reuben JM, et al (2004). Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine, 25, 94-102. https://doi.org/10.1016/j.cyto.2003.10.004
  16. Kusumanto YH , Dam WA, Hospers GA, Meijer C, Mulder NH (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-7. https://doi.org/10.1023/B:AGEN.0000029415.62384.ba
  17. Sezer H, Yilmaz M, Gurler H, Koyuncu A (2011). Breast cancer risk factors in Turkey: a hospital-based case-control study. Asian Pac J Cancer Prev, 12, 2317-22.
  18. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
  19. Sotiriou C, Neo SY, McShane LM, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8. https://doi.org/10.1073/pnas.1732912100
  20. Tenesa A, Theodoratou E, Din FV, et al (2010). Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin Cancer Res, 16, 3754-9. https://doi.org/10.1158/1078-0432.CCR-10-0439

Cited by

  1. Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2245
  2. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma vol.29, pp.7, 2015, https://doi.org/10.1111/dote.12401
  3. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/9503025
  4. Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients vol.96, pp.45, 2017, https://doi.org/10.1097/MD.0000000000008101
  5. Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer vol.113, pp.1, 2015, https://doi.org/10.1038/bjc.2015.183
  6. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer vol.14, pp.5, 2018, https://doi.org/10.1111/ajco.12871
  7. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer vol.97, pp.49, 2018, https://doi.org/10.1097/MD.0000000000013340